Cellular immune reconstitution after haploidentical transplantation in children.

[1]  K. Dietz,et al.  Intensity of HLA class I expression and KIR‐mismatch determine NK‐cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia , 2007, British journal of haematology.

[2]  R. Handgretinger,et al.  Feasibility and Outcome of Reduced‐Intensity Conditioning in Haploidentical Transplantation , 2007, Annals of the New York Academy of Sciences.

[3]  C. Naeve,et al.  A novel approach for the analysis of T-cell reconstitution by using a T-cell receptor beta-based oligonucleotide microarray in hematopoietic stem cell transplantation. , 2007, Experimental hematology.

[4]  M. Ebinger,et al.  Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation , 2007, Bone Marrow Transplantation.

[5]  P. Conti,et al.  IL-15 an immunoregulatory and anti-cancer cytokine. Recent advances. , 2006, Journal of experimental & clinical cancer research : CR.

[6]  J. Passweg,et al.  Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation. , 2006, Best practice & research. Clinical haematology.

[7]  A. Kelleher,et al.  The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostasis and the challenges facing its utilization as a novel therapy. , 2006, Current drug targets.

[8]  S. Shurtleff,et al.  Rapid immune reconstitution after a reduced‐intensity conditioning regimen and a CD3‐depleted haploidentical stem cell graft for paediatric refractory haematological malignancies , 2006, British journal of haematology.

[9]  R. Krance,et al.  Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. , 2006, Blood.

[10]  T. Lion,et al.  Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation , 2006, British journal of haematology.

[11]  D. Srivastava,et al.  Haploidentical Stem Cell Transplantation with CD3 Depleted Mobilized Peripheral Blood Stem Cell Grafts for Children with Hematologic Malignancies. , 2005 .

[12]  T. Klingebiel,et al.  A Comparison between Three Graft Manipulation Methods for Haploidentical Stem Cell Transplantation in Pediatric Patients: Preliminary Results of a Pilot Study , 2005, Klinische Pädiatrie.

[13]  R. Handgretinger,et al.  Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation , 2005, Bone Marrow Transplantation.

[14]  F. Behm,et al.  Comparison of Killer Ig-Like Receptor Genotyping and Phenotyping for Selection of Allogeneic Blood Stem Cell Donors1 , 2005, The Journal of Immunology.

[15]  T. Klingebiel,et al.  Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. , 2005, Pathologie-biologie.

[16]  S. Shurtleff,et al.  Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. , 2005, Blood.

[17]  S. Zimmermann,et al.  A novel four-colour flow cytometric assay to determine natural killer cell or T-cell-mediated cellular cytotoxicity against leukaemic cells in peripheral or bone marrow specimens containing greater than 20% of normal cells. , 2005, Journal of immunological methods.

[18]  G. Fey,et al.  Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. , 2004, Blood.

[19]  K. Dietz,et al.  Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  D. Campana,et al.  Minimal Residual Disease Studies by Flow Cytometry in Acute Leukemia , 2004, Acta Haematologica.

[21]  R. Handgretinger,et al.  Determinants of Antileukemia Effects of Allogeneic NK Cells 1 , 2004, The Journal of Immunology.

[22]  R. Handgretinger,et al.  A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation. , 2004, Cytotherapy.

[23]  R. Handgretinger,et al.  A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells , 2002, Bone Marrow Transplantation.

[24]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[25]  M. Martelli,et al.  Transplants across human leukocyte antigen barriers. , 2002, Seminars in hematology.

[26]  T. Klingebiel,et al.  Immunological Aspects of Haploidentical Stem Cell Transplantation in Children , 2001, Annals of the New York Academy of Sciences.

[27]  T. Klingebiel,et al.  Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children , 2001, Bone Marrow Transplantation.

[28]  M. Martelli,et al.  Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor. , 2000, Current opinion in immunology.

[29]  J. Klein,et al.  T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. , 2000, Blood.

[30]  M. Martelli,et al.  Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.

[31]  E. Romond,et al.  Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant. , 1996, Transplantation.

[32]  J. Thompson,et al.  T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect. , 1987, Transplantation proceedings.

[33]  B. Dupont,et al.  Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. , 1983, Blood.